paxilline has been researched along with metoprolol in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dell'italia, LJ; Dillon, R; Kolpakov, MA; Rafiq, K; Sabri, A; Seqqat, R | 1 |
1 other study(ies) available for paxilline and metoprolol
| Article | Year |
|---|---|
Sympathetic activation causes focal adhesion signaling alteration in early compensated volume overload attributable to isolated mitral regurgitation in the dog.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Apoptosis; Cells, Cultured; Collagen; Crk-Associated Substrate Protein; Disease Models, Animal; Dogs; Focal Adhesion Protein-Tyrosine Kinases; Focal Adhesions; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; Hypertrophy, Left Ventricular; Metoprolol; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitral Valve Insufficiency; Myocardium; Neoplasm Proteins; p38 Mitogen-Activated Protein Kinases; Paxillin; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptors, Adrenergic, beta-1; Signal Transduction; Sympathetic Nervous System; Ventricular Function, Left; Ventricular Remodeling | 2008 |